✦ LIBER ✦

Re: Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of three pivotal, randomised, phase 3 trials

✍ Scribed by Araki, Kazuhiro; Ito, Yoshinori; Takahashi, Shunji

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Superiority of denosumab to zoledronic a

✍ Allan Lipton; Karim Fizazi; Alison T. Stopeck; David H. Henry; Janet E. Brown; D 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 612 KB

3061 POSTER Prevention of Skeletal-Relat

✍ A. Lipton; K. Fizazi; A.T. Stopeck; D.H. Henry; J.E. Brown; F. Saad; D. Yardley; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Interpreting results from oncology clini

✍ George Dranitsaris, Eleftheria Hatzimichael 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 164 KB

AOS13 Denosumab versus zoledronic acid f

✍ A.T. Stopeck; G. Richardson; S. Siena; A. Lipton; J. Brown; K. Fizazi; D. Henry; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Delaying skeletal-related events in a ra

✍ Henry, David; Vadhan-Raj, Saroj; Hirsh, Vera; Moos, Roger; Hungria, Vania; Costa 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 315 KB

Incidence and outcomes of osteonecrosis

✍ J.E. Brown*; C.H. Barrios; I.J. Diel; T. Facon; K. Fizazi; T. Ibrahim; F. Saad; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 71 KB